Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmacist Education Programs On Homeopathy, Supplements Urged

This article was originally published in The Tan Sheet

Executive Summary

The increasing popularity of homeopathic remedies has created the need for improved pharmacist education programs and heightened consumer awareness, according to an article in the March/April issue of the Journal of the American Pharmaceutical Association.

You may also be interested in...



Health Care Provider, Supplement Firm Interaction Urged By APhA, ADA

Health care professionals should personally contact the manufacturers of dietary supplements to gather information on specific products used by their patients, the American Pharmaceutical Association and American Dietetic Association suggest in a guidebook released Aug. 17.

Health Care Provider, Supplement Firm Interaction Urged By APhA, ADA

Health care professionals should personally contact the manufacturers of dietary supplements to gather information on specific products used by their patients, the American Pharmaceutical Association and American Dietetic Association suggest in a guidebook released Aug. 17.

Health Care Provider, Supplement Firm Interaction Urged By APhA, ADA

Health care professionals should personally contact the manufacturers of dietary supplements to gather information on specific products used by their patients, the American Pharmaceutical Association and American Dietetic Association suggest in a guidebook released Aug. 17.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090966

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel